Drawing for EVOLET

USPTO serial 79168379

EVOLET

Reviewed by CopyMark Law Group

Reg. 4911522Status 404
Filing date
Status date
Registration date
Mar 8, 2016
Examiner
FLETCHER, TRACY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EVOLET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Adhesive tapes for medical purposes; alcohol for pharmaceutical purposes; antiallergic medicines; antibiotics; pharmaceutical antitussive-cold preparations; baby foods; balsamic preparations for medical purposes in the nature of Gurjun balsam for medical purposes; biological preparations for the treatment of some gynaecological diseases and cancer; cardiovascular pharmaceutical preparations; chemical reagents for medical diagnostic purposes; chemical preparations for pharmaceutical purposes, namely, for blood disorders, cancer and cardiovascular diseases; medical diagnostic chemical reagents for the diagnosis of diabetes; pharmaceutical compounds for treating respiratory diseases; cough syrups; court plaster; dietary supplement drinks; dietary supplements; dietary supplements for humans and animals; dietary supplements for infants; dietary supplements for medical use; dietetic beverages adapted for medical purposes; dietetic confectionery adapted for medical purposes; dietetic food adapted for medical and veterinary use, namely, bread, cookies and crackers; food for babies; dietetic foods for medical use adapted for babies, namely, crackers, infant formula and biscuits; dietetic foods for medical use adapted for invalids, namely, bread, cookies and crackers; medicinal infusions for treating diabetes; dietetic preparations adapted for medical use, namely; dietetic sugar and sugar substitutes for medical use; all-purpose disinfectants; disinfectants for hygiene purposes; pharmaceutical preparations, namely, elixirs for preventing and relieving chills in the treatment of colds and flu; pharmaceutical preparations, namely, elixirs for preventing colds; pharmaceutical preparations, namely, elixirs for treating asthma; enzyme dietary supplements; enzyme preparations for medical purposes; enzymes for medical purposes; eye drops; eye lotions for medical use; eye ointment for medical use; food for diabetics, namely, crackers and cookies; food supplements for dietetic use; foodstuffs for diabetics, namely, crackers and cookies; gastrointestinal preparations for medical use; glucose dietary supplements; glucose for medical purposes; glucose preparations for medical purposes; hypnotic sedatives; hypnotics; immunoassay reagents for medical use; pharmaceutical preparations, namely, immunomodulators; dietary supplement mineral drinks; mineral food supplements; dietary supplement mineral waters for medical purposes; multivitamins; nasal decongestants; nutritional supplements; antibiotic ointments for pharmaceutical purposes; pain relief medication; pharmaceutical and veterinary preparations, namely, antibiotics; pharmaceutical compositions, namely, antibiotics; pharmaceutical creams, namely, medicated skin creams; pharmaceutical implants, namely, implants comprising living tissue; medicated lip salves; pharmaceutical veterinary preparations for skin care; pharmaceutical preparations for animals, namely, vaccines; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for veterinary use, namely, antibiotics; pharmaceutical preparations in strip form for the treatment of varicose veins; pharmaceutical skin lotions; pharmaceuticals for the treatment of erectile dysfunction; preparations for destroying pests; preparations for destroying vermin; preparations for ocular lubrication, namely, eye drops and eye washes; nutritional food additives for medical purposes in the nature of natural food extracts derived from vegetables; sanitary knickers in the nature of panties; sanitary napkins; sanitary pads; sanitary panties; sanitary preparations for medical purposes; sanitary tampons; sanitary towels; siccatives for medical purposes; skin care creams for medical use; medicated skin care lotions; pharmaceutical preparations for the treatment of dry skin; sticking medical plasters; styptic pencils; milk sugar for medical purposes; sugar substitutes for medical use for diabetics; tampons; medicated therapeutic skin creams; tonics, namely, pharmaceutical preparations for treatment of sore throat; tranquillizers; vitamin drinks; vitamin preparations; vitamins for animalsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 13, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 21, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 26, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 26, 2023INPCINVALIDATION PROCESSED—
May 23, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 23, 2022C71TCANCELLED SECTION 71—
Mar 8, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 5, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 26, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 9, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 21, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 21, 2016FIMPFINAL DISPOSITION PROCESSED—
Jun 8, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 22, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 22, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 2, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 19, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 1, 2015RFNTREFUSAL PROCESSED BY IB—
Jul 15, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 15, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 14, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 14, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 13, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2015DOCKASSIGNED TO EXAMINER—
Jul 10, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance